CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Arizona State Physicians Association (ASPA)

Arizona State Physicians Association (ASPA) is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Recombinant Data

Recombinant Data Corp. is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Talyst

Talyst enables positive change in the medication management process.

Westphalia Retirement Ctr

Westphalia Retirement Ctr is a Westphalia, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Valir Health

Valir Health is a comprehensive healthcare organization specializing in a full range of medical services. Our entities include a physical rehabilitation hospital, 15 physical therapy clinics, a hospice division, a fitness center, (PACE) a Program of All-inclusive Care for the Elderly, acupuncture clinic, corporate health and safety services and programs, and medical consulting and billing services. Valir Health provides uncompromised service to each patient and client we serve, we are committed to establishing a higher standard through strength, courage, and character. Driven by our motto, "Do the right thing," Valir has continued to grow through positive physician and patient referrals and strong business relationship development.